CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.
Condition(s):Depressive Disorder, MajorLast Updated:May 17, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, MajorLast Updated:May 17, 2011Completed
Condition(s):BDLast Updated:December 24, 2013Unknown status
Condition(s):Attention Deficit Disorder With Hyperactivity; Methylphenidate; PharmacogeneticsLast Updated:October 5, 2011Completed
Condition(s):PainLast Updated:February 29, 2024Recruiting
Condition(s):ADHDLast Updated:December 20, 2023Recruiting
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:May 17, 2011Completed
Condition(s):ADHD; Attention Deficit Hyperactivity DisorderLast Updated:November 16, 2012Completed
Condition(s):Autism Spectrum Disorder; Attention Deficit Hyperactivity DisorderLast Updated:January 15, 2021Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:May 9, 2014Completed
Condition(s):Attention Deficit Hyperactivity Disorder; ADHDLast Updated:February 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.